Introduction

Despite being arguably the second most common dementing disorder, dementia with Lewy bodies, aka DLB, remains both mysterious and understudied.  On Tuesday, October 10, 2017, the Lewy Body Dementia Association and Alzforum co-hosted a webinar discussion with DLB research leaders Ian McKeith and John-Paul Taylor, both at Newcastle University, England, U.K. The conversation was inspired by new consensus criteria for the diagnosis and management of DLB. The DLB Consortium had published the new criteria in the journal Neurology earlier this year (Jun 2017 news). Growing out of the International Dementia with Lewy Body Conference, held December 2015 in Fort Lauderdale, Florida, the updated criteria were co-authored by most leaders of this small global research community. The criteria elevate the importance of REM sleep disorder and incorporate the biomarker MIBG, among other changes. McKeith and colleagues hope that the new diagnostic and management guidelines will help clinicians catch more DLB cases. They also hope that the criteria will make this combined cognition and movement disorder more tractable for biomarker research, longitudinal cohorts, and clinical trials. Have you adopted the guidelines? What’s working, what’s not? How are they informing your research? Read the open access paper here, then view the slides and hear the discussion. Introduction by Angela Taylor, LBDA; moderation by Gabrielle Strobel, Alzforum.

Media

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

News Citations

1. DLB Guidelines Get a Makeover 16 Jun 2017
2. Dementia with Lewy Bodies: Is the Research Ready For Clinical Trials 22 Dec 2015

External Citations

1. Lewy Body Dementia Association
2. here

Further Reading

No Available Further Reading